Emmaus Life Sciences Announces Collaboration with Kier (Junior) Spates to Share Personal Experience with Sickle Cell Disease and Endari® Sep 28, 2022 6:30am EDT
Emmaus Life Sciences Reports Q2 2022 Financial Results and Provides Business Update Aug 15, 2022 4:30pm EDT
Emmaus Life Sciences Announces Engagement of Strategic Business Relations and Professional Services Advisor Jul 12, 2022 10:00am EDT
Emmaus Life Sciences Reports Q1 2022 Financial Results and Provides Business Update May 13, 2022 8:23am EDT
Emmaus Life Sciences Presented Positive Real-World Data on the Efficacy of Endari® in Preventing Acute Complications from Sickle Cell Disease at the 62nd Annual Scientific Meeting of the British Society for Haematology Apr 07, 2022 8:23am EDT
Emmaus Life Sciences Reports 2021 Financial Results and Provides Business Update Mar 31, 2022 5:24pm EDT
